The FDA has granted Fast Track designation to LPCN 1148 for the treatment of sarcopenia in patients with decompensated cirrhosis.

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

Calling people "mentally ill" based on their sexual identity and referring to women as "household objects" will now be allowed in the context of political discussions on social media giant Meta's ...